Douglas M. Fambrough, III
2017
In 2017, Douglas M. Fambrough, III earned a total compensation of $1.2M as President and Chief Executive Officer at Dicerna Pharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $261,043 |
|---|---|
| Option Awards | $467,498 |
| Salary | $490,000 |
| Other | $18,492 |
| Total | $1,237,033 |
Fambrough received $490K in salary, accounting for 40% of the total pay in 2017.
Fambrough also received $261K in non-equity incentive plan, $467.5K in option awards and $18.5K in other compensation.
Rankings
In 2017, Douglas M. Fambrough, III's compensation ranked 7,958th out of 14,666 executives tracked by ExecPay. In other words, Fambrough earned more than 45.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,958 out of 14,666 | 46th |
Division Manufacturing | 2,986 out of 5,772 | 48th |
Major group Chemicals And Allied Products | 978 out of 2,075 | 53rd |
Industry group Drugs | 764 out of 1,731 | 56th |
Industry Pharmaceutical Preparations | 601 out of 1,333 | 55th |
Source: SEC filing on April 26, 2018.
Fambrough's colleagues
We found two more compensation records of executives who worked with Douglas M. Fambrough, III at Dicerna Pharmaceuticals in 2017.